FDA Approved Drug for Rare Cushing’s Disease

admin Mar 10, 2020

Cushing disease can cause abdominal stretchmarks, red cheeks, fatty hump between shoulders, pendulous abdomen and thin arms and legs.

The US Food and Drug Administration approved an oral tablet, Isturisa, for adults with Cushing’s disease, on Friday. This drug is targeted at individuals that cannot undergo pituitary gland surgery or have undergone the surgery but are still affected by the disease.


FDA In Brief: FDA Encourages Inclusion of Older Adult Patients in Cancer Clinical Trials

admin Mar 05, 2020

The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research:
“Enrolling a broad representation of patients in clinical trials is an important tenet of clinical research as it facilitates a better understanding of the drug’s benefits and risks across the patient population likely to take the drug. However, because cancer incidence increases with age, and given the aging U.S. population, it’s particularly important now more than ever to ensure that older adults are also enrolling in cancer clinical trials.